| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Pediatric Metabolic–Neurogenetic Unit (Drs. Nissenkorn, Michelson, and Lerman–Sagie), Wolfson Medical Center, Holon; and the Pediatric Neurology Unit (B. Ben-Zeev), Sheba Medical Center, Israel.
Address correspondence and reprint requests to Dr. Tally Lerman–Sagie, Pediatric Neurology Unit, Wolfson Medical Center, POB 5, Holon 58100, Israel; e-mail: asagie{at}ccsg.tau.ac.il
Brain malformations are caused by a disruption in the sequence of normal development by various environmental or genetic factors. By modifying the intrauterine milieu, inborn errors of metabolism may cause brain dysgenesis. However, this association is typically described in single case reports. The authors review the relationship between brain dysgenesis and specific inborn errors of metabolism. Peroxisomal disorders and fatty acid oxidation defects can produce migration defects. Pyruvate dehydrogenase deficiency, nonketotic hyperglycinemia, and maternal phenylketonuria preferentially cause a dysgenetic corpus callosum. Abnormal metabolism of folic acid causes neural tube defects, whereas defects in cholesterol metabolism may produce holoprosencephaly. Various mechanisms have been proposed to explain abnormal brain development in inborn errors of metabolism: production of a toxic or energy-deficient intrauterine milieu, modification of the content and function of membranes, or disturbance of the normal expression of intrauterine genes responsible for morphogenesis. The recognition of a metabolic disorder as the cause of the brain malformation has implications for both the care of the patient and for genetic counseling to prevent recurrence in subsequent pregnancies.
This article has been cited by other articles:
|
|
 |
|
  M. C. Y. de Wit, M. H. Lequin, I. F. M. de Coo, E. Brusse, D. J. J. Halley, R. van de Graaf, R. Schot, F. W. Verheijen, and G. M. S. Mancini Cortical Brain Malformations: Effect of Clinical, Neuroradiological, and Modern Genetic Classification Arch Neurol, March 1, 2008; 65(3): 358 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Pisani, C. Cerminara, C. Fusco, and L. Sisti Neonatal status epilepticus vs recurrent neonatal seizures: Clinical findings and outcome Neurology, December 4, 2007; 69(23): 2177 - 2185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Henwood, P. S. Thornton, C. M. Preis, C. Chee, and A. Grimberg Reconciling Diabetes Management and the Ketogenic Diet in a Child with Pyruvate Dehydrogenase Deficiency J Child Neurol, May 1, 2006; 21(5): 436 - 439. [Abstract] [PDF]
|
|
|
|
 |
|
 J. S. Hahn and D. M. Olson Etiology of Neonatal Seizures NeoReviews, August 1, 2004; 5(8): e327 - e335. [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. W. Groenen, I. A. L. M. van Rooij, P. G. M. Peer, M. C. Ocke, G. A. Zielhuis, and R. P. M. Steegers-Theunissen Low Maternal Dietary Intakes of Iron, Magnesium, and Niacin Are Associated with Spina Bifida in the Offspring J. Nutr., June 1, 2004; 134(6): 1516 - 1522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Nardacci, I. Falciatori, S. Moreno, and S. Stefanini Immunohistochemical Localization of Peroxisomal Enzymes During Rat Embryonic Development J. Histochem. Cytochem., April 1, 2004; 52(4): 423 - 436. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Zand, E. M. Simon, S. B. Pulitzer, D.J. Wang, Z.J. Wang, L. B. Rorke, M. Palmieri, and G. T. Berry In Vivo Pyruvate Detected by MR Spectroscopy in Neonatal Pyruvate Dehydrogenase Deficiency AJNR Am. J. Neuroradiol., August 1, 2003; 24(7): 1471 - 1474. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
